Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)

Inclusion Criteria:

- Male or Female 18 - 84 years of age, inclusive, who have been diagnosed with IBD.

- Willing to provide a stool sample ≤120 but ≥7 days after a surveillance colonoscopy,
which was negative for cancer/dysplasia.

- Written informed consent document signed and dated by the subject.

Exclusion Criteria:

- Any condition that in the opinion of the investigator should preclude participation
in the study.

- A history of aerodigestive tract cancer.

- Prior colorectal resection, except ileocolic resection in Crohn's disease patients.

- IBD limited only to the rectum.

- Subject has participated in any clinical study within the previous 30 days wherein an
investigational compound or device was, or may have been, introduced into the
subject.